1. Ludwig Institute for Cancer Research Limited (10 from 525 patents)

2. Cornell Research Foundation Inc. (4 from 1,521 patents)

3. Sloan-kettering Institute for Cancer Research (3 from 512 patents)

4. Memorial Sloan Kettering Cancer Center (2 from 559 patents)

5. Other (1 from 832,843 patents)

6. Institute of Molecular Biology and Genetics National Academy of Science of Ukraine (1 from 3 patents)

7. Institute of Molecular Biology and Genetics National Academy of Sciences of Ukraine (0 patent)

1. 8603474 - Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

2. 8440807 - A34 and A33-like 3 DNA protein, antibodies thereto and methods of treatment using same

3. 8071717 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

4. 7795409 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof

5. 7622568 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

6. 7521543 - A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same

7. 7354992 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

8. 7132507 - Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses

9. 6911529 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

10. 6774226 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

11. 6448073 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

12. 5009995 - Monoclonal antibodies to melanoma cells

13. 4806628 - Monoclonal antibodies against melanocytes